September 18, 2024
SAN DIEGO -- #100MillionCellChallenge--Scale Biosciences (Scale Bio), a leader in innovative and scalable single cell analysis solutions, today announced that the Chan Zuckerberg Initiative (CZI) has joined as a partner in the groundbreaking ‘100 Million Cell Challenge.’ CZI will fully subsidize support for 50 million cells’ worth of awarded projects. This partnership comes on the heels of [...]
September 18, 2024
High performance two-plasmid production system achieves E12 vg/mL unconcentrated titers AI-driven design tools to improve expression precision, efficacy, and manufacturability Boston, Massachusetts: Asimov, the synthetic biology company advancing the design and production of therapeutics, today announced the launch of the AAV Edge System, a comprehensive suite of tools for adeno-associated viral (AAV) gene therapy design [...]
In a Key Win for Parse, Patent Trial and Appeal Board Invalidates 10x Genomics Patent Claims
September 18, 2024
SEATTLE — Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, today announced that on September 17, 2024, the Patent Trial and Appeal Board (PTAB) of the United States Patent and Trademark Office (USPTO) issued a decision to invalidate all claims in the 10,155,981 patent that 10x Genomics had previously asserted against [...]
September 18, 2024
SAN DIEGO--#100MillionCellChallenge--Scale Biosciences (Scale Bio), a leader in innovative and scalable single cell analysis solutions, today announced that the Chan Zuckerberg Initiative (CZI) has joined as a partner in the groundbreaking ‘100 Million Cell Challenge.’ CZI will fully subsidize support for 50 million cells’ worth of awarded projects. This partnership comes on the heels of [...]
Zymo Research Stands by Its Innovative cfDNA Technology in Response to Qiagen’s Lawsuit
September 18, 2024
Irvine, CA — Zymo Research Corporation, a leader in innovative life science solutions, acknowledges the patent infringement lawsuit filed by Qiagen GmbH on August 20, 2024, at the US District Court for the Central District of California regarding its MAGicBead cfDNA isolation technology. Zymo Research respects intellectual property rights and is confident that this technology represents [...]
In a Key Win for Parse, Patent Trial and Appeal Board Invalidates 10x Genomics Patent Claims
September 18, 2024
SEATTLE — Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, today announced that on September 17, 2024, the Patent Trial and Appeal Board (PTAB) of the United States Patent and Trademark Office (USPTO) issued a decision to invalidate all claims in the 10,155,981 patent that 10x Genomics had previously asserted [...]
Zymo Research Stands by Its Innovative cfDNA Technology in Response to Qiagen’s Lawsuit
September 18, 2024
Irvine, CA — Zymo Research Corporation, a leader in innovative life science solutions, acknowledges the patent infringement lawsuit filed by Qiagen GmbH on August 20, 2024, at the US District Court for the Central District of California regarding its MAGicBead cfDNA isolation technology. Zymo Research respects intellectual property rights and is confident that this technology [...]
September 17, 2024
Tokyo, Japan – JSR Life Sciences, a JSR Group company, today announced the launch of its next generation protein A chromatography resin, Amsphere™ A+. The resin will be presented at the BioProcess International Conference & Exhibition (BPI) 2024, September 23-26, 2024, in Boston, USA and at BioJapan to be held at Pacifico Yokohama from October [...]
ScaleReady announces a G-Rex® Grant has been awarded to Verismo Therapeutics
September 17, 2024
ST. PAUL, Minn. -- ScaleReadyTM, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation (NASDAQ: TECH), and CellReadyTM, today announced that it has awarded a $150,000 G-Rex Grant to Verismo Therapeutics, a clinical-stage CAR T company developing the novel KIR-CAR platform technology. This grant will support Verismo Therapeutics' ongoing efforts to optimize the development and manufacturing of its KIR-CAR [...]
Zetta proudly announces the appointment of Bram Goorden as Non-Executive Director
September 17, 2024
Accomplished Genomics Leader, Bram Goorden, with extensive expertise in Life Sciences joins Zetta Genomics as Non-Executive Director, bringing proven track record of Innovation and global impact in preparation for Series A fundraise. Bram is an accomplished Chief Executive Officer with over two decades of experience in the life sciences industry and joins to support the [...]

